Loading organizations...
§ Private Profile · Berlin, Berlin, Germany
Biotech develops TCR-T therapies for solid tumors. Improves T cell persistence & anti-tumor activity via proprietary tech.
Based in Schoenefeld, Germany, Captain T Cell is a biotechnology startup developing enhanced efficacy TCR-T cell therapies targeting solid tumors that are underserved by existing treatments. The organization utilizes a proprietary genetic toolbox designed to improve T cell persistence, resilience, and overall antitumor activity within hostile tumor microenvironments. The company has secured €20 million in total funding to date, which includes an €8.5 million seed round alongside nondilutive grants from the German Federal Ministry of Education and Research. This capital supports the advancement of its lead autologous candidate, CTC127, into Phase I clinical trials, backed by institutional investors such as i&i Biotech Fund I SCSp, Brandenburg Kapital GmbH, and HIL-INVENT. Captain T Cell was founded by CEO Dr. Felix Lorenz alongside a team of oncology experts as a technology spinoff from the Max Delbrück Center for Molecular Medicine.
Captain T Cell has raised $32.4M across 2 funding rounds.
Captain T Cell has raised $32.4M in total across 2 funding rounds.
Captain T Cell has raised $32.4M across 2 funding rounds. Most recently, it raised $23.2M Other Equity in November 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 19, 2025 | $23.2M Venture Round | PD DR. Med. Theis Terwey, Andreas Schmidt | Brandenburg Kapital, HIL Invent, Barbora Šumová, Sintra Limited, Technologiegründerfonds Sachsen | Announced |
| May 22, 2024 | $9.2M Seed | — | NAM Nguyen, Germany, Friedrich Hillebrand, Jaromir Zahradka | Announced |
Captain T Cell has raised $32.4M in total across 2 funding rounds.
Captain T Cell's investors include PD Dr. med. Theis Terwey, Andreas Schmidt, Brandenburg Kapital, Hil-Invent, Barbora Šumová, Sintra Limited, Technologiegründerfonds Sachsen, Nam Nguyen, Germany, Friedrich Hillebrand, Jaromir Zahradka.